- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 182.39M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.68M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $621.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $585.01M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.95B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.02B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $518.45M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $557.51M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.96B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.03B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 193.07M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $6.55M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $208.68M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.32B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.26B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.29 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.30 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $168.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | $56.24M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $129.95M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $316.89M |
| Revenue | Q1 2025 · Mar 31, 2024 | $587.18M |